Int. Journal of Clinical Pharmacology and Therapeutics, Volume 45 - November (598 - 600)

The association of interferon with the development of pulmonary tuberculosis
R. Farah, J. Awad
1 Department of Internal Medicine F, 2 Internal Medicine A Department, Western Galilee Hospital, Nahariya, Israel

Add to Cart  

 

DOI 10.5414/CPP45598

Abstract

We report a new case of a patient suffering from chronic hepatitis C (CHC) and treated with interferon-α2a (IFN-α) who presented with the diagnosis of active pulmonary tuberculosis. Interferon was stopped and appropriate treatment with antituberculous drugs initiated. Several weeks later the patient was free of clinical symptoms. Our case demonstrates a rare association between interferon and tuberculosis since only one case in the literature has described a similar association.

Author Details

Authors

Departments

  • 1 Department of Internal Medicine F,
  • 2 Internal Medicine A Department, Western Galilee Hospital, Nahariya, Israel

Address

R. Farah, MD, Herzel Str. 122/7 Nahariya 22448, Department of Internal Medicine F, Western Galilee Hospital, P.O.B. 21, Nahariya 22100, Israel
Email: [email protected]

Citation

R. Farah and J. Awad.The association of interferon with the development of pulmonary tuberculosis. 2007; 45: 598-600. doi: 10.5414/CPP45598.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart